Close
ACHEMA MIDDLE EAST 2026

Japan Approves Daiichi Sankyo Blood Cancer Drug Ezharmia

Daiichi Sankyo, a Japanese company, has been concentrating on a series of antibody-drug conjugates, but it has achieved a world first in a field...

Alzheimers Medicine Change Helped Biden Win Medicare Costs

Despite the fact that the decision to severely restrict coverage of an expensive new Alzheimer's medicine, U.S. President Joe Biden celebrated success on September...

Testing Expert: Omicron Infection Protects Against Influenza

Everyone eligible for both shots will often receive them at the same time during the COVID and flu vaccination campaigns in the fall. Interestingly,...

Australia Encourages Further COVID-19 Vaccination Research

In order to ultimately enhance the outcomes and care for children and people with chronic conditions, especially as novel variants emerge, the Australian government...

Amyotrophic Lateral Sclerosis- FDA And NIH Learning More

The Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership created to advance the development of treatments for amyotrophic lateral sclerosis (ALS)...

US Study Finds COVID Raises Long-Term Brain Injury Risk

According to a study published on September 22nd by U.S. researchers, those who had COVID-19 were more likely to experience a variety of brain damage...

Herpes By Being Genetically Altered Fights Severe Cancers

A quarter of patients with a variety of advanced tumours have shown signals of benefit from RP2, a modified form of the herpes simplex...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...